Search Results - "BAIRN, Donald S"

Effect of baseline thrombus in the SAFER (saphenous vein graft angioplasty free of emboli randomized) trial by Girt, Salvendra, Kuntz, Richard E., Eisenhauer, Andrew C., Popma, Jeffrey J., Prpic, Ross, Kaya, Unsal, Rogers, Campbell, Bairn, Donald S.

Get full text

Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation by STONE, Gregg W, ELLIS, Stephen G, COLOMBO, Antonio, DAWKINS, Keith D, GRUBE, Eberhard, CUTLIP, Donald E, FRIEDMAN, Mark, BAIRN, Donald S, KOGLIN, Joerg

“…Drug-eluting stents compared with bare metal stents (BMS) may increase late stent thrombosis (ST), although an accompanying increase in the rates of death and…”
Get full text

Saphenous Vein Graft Stenting and Major Adverse Cardiac Events : A Predictive Model Derived From a Pooled Analysis of 3958 Patients by COOLONG, Alanna, BAIRN, Donald S, KUNTZ, Richard E, O'MALLEY, A. James, MARULKAR, Sachin, CUTLIP, Donald E, POPMA, Jeffrey J, MAURI, Laura

“…Treatment of saphenous vein graft (SVG) stenosis with percutaneous coronary intervention has a 15% to 20% incidence of major adverse cardiac events (MACE)…”
Get full text

Percutaneous recanalization of chronically occluded coronary arteries : A consensus document Part II by STONE, Gregg W, REIFART, Nicolaus J, MINTZ, Gary S, KATOH, Osamu, MITSUDO, Kazuaki, SUZUKI, Takahiko, TAMAI, Hideo, GRUBE, Eberhard, CANNON, Louis A, KANDZARI, David E, REISMAN, Mark, SCHWARTZ, Robert S, MOUSSA, Issam, BAILEY, Steven, DANGAS, George, MEHRAN, Roxana, ABIZAID, Alexander, MOSES, Jeffrey W, LEON, Martin B, SERRUYS, Patrick W, HOYE, Angela, COX, David A, COLOMBO, Antonio, BAIRN, Donald S, TEIRSTEIN, Paul S, STRAUSS, Bradley H, SELMON, Matthew

Get full text

Thrombotic and Hemorrhagic Complications of Stenting Coronary Arteries: Incidence, Management, and Prevention by Carrozza, JP, Baim, DS

“…Stents are intravascular prostheses which provide endoluminal scaffolding, effectively reducing elastic recoil and sealing local dissections. Stents have…”
Get full text

Cardiogenic shock induced by cocaine in swine with normal coronary arteries by Núñez, B D, Miao, L, Kuntz, R E, Ross, J N, Gladstone, S, Baim, D S, Gordon, P C, Morgan, J P, Carrozza, Jr, J P

“…The aim was to test the hypothesis that acute intravenous cocaine administration can cause coronary microvascular constriction culminating in myocardial…”
Get more information

Acute results of directional coronary atherectomy in the Balloon Versus Optimal Atherectomy Trial (BOAT) pilot phase by Baim, D S, Cutlip, D, Ho, K K, Popma, J J, Senerchia, C, Kuntz, R E

Get more information

Effect of Diabetes Mellitus on Five-Year Clinical Outcomes After Single-Vessel Coronary Stenting (a Pooled Analysis of Coronary Stent Clinical Trials) by Lee, Tobias T., Feinberg, Loryn, Baim, Donald S., Holmes, David R., Aroesty, Julian M., Carrozza, Joseph P., Cohen, David J., Ho, Kalon K.L., Cutlip, Donald E.

“…Diabetes mellitus (DM) increases the risk of clinically driven, repeat revascularization of the stented lesion in the first year after coronary stenting. The…”
Get full text

Differential Effects Between Intravenous and Targeted Renal Delivery of Fenoldopam on Renal Function and Blood Pressure in Patients Undergoing Cardiac Catheterization by Teirstein, Paul S., Price, Matthew J., Mathur, Vandana S., Madyoon, Hooman, Sawhney, Neil, Baim, Donald S.

“…A randomized, controlled clinical trial demonstrated that intravenous (IV) fenoldopam did not prevent further deterioration in renal function after contrast…”
Get full text

Effect of Prolonged Thienopyridine Use After Drug-Eluting Stent Implantation (from the TAXUS Landmark Trials Data) by Stone, Gregg W., MD, Ellis, Stephen G., MD, Colombo, Antonio, MD, Grube, Eberhard, MD, Dawkins, Keith D., MD, Friedman, Mark, MD, Baim, Donald S., MD

“…Previous observational studies have evaluated the utility of prolonged thienopyridine therapy in patients receiving drug-eluting stents, with conflicting…”
Get full text

One-Year Outcomes from the TAXUS Express Stent Versus Cypher Stent by Mayor, Manuel, MD, Malik, Amir Z., MD, Minor, Robert J., MD, Deshpande, Mahesh C., MS, MBA, Strauss, William E., MD, Maloney, Thomas H., MS, Baim, Donald S., MD, O'Neill, William, MD, Kandzari, David E., MD

“…We compared 1-year outcomes in patients treated with paclitaxel-eluting stents (PESs) or sirolimus-eluting stents (SESs) in “real-world” clinical practice…”
Get full text

Postmarket surveillance for drug-eluting coronary stents : A comprehensive approach by BAIRN, Donald S, MEHRAN, Roxana, KEREIAKES, Dean J, GROSS, Thomas P, SIMONS, Michael, MALENKA, David, KAPLAN, Aaron V

Get full text

TRANSENDOCARDIAL AND TRANSEPICARDIAL INTRAMYOCARDIAL FIBROBLAST GROWTH FACTOR-2 ADMINISTRATION: MYOCARDIAL AND TISSUE DISTRIBUTION by Roger J. Laham, Mark Post, Mehrdad Rezaee, Laurel Donnell-Fink, Joanna J. Wykrzykowska, Seung U. Lee, Donald S. Baim, Frank W. Sellke

“…Effective local delivery to the heart remains an obstacle to successful therapeutic application of a number of drugs and biological agents. This study was…”
Get full text

Frequency of Coronary Artery Bypass Grafting Following Implantation of a Paclitaxel -Eluting or a Bare-Metal Stent Into a Single Coronary Artery by Martin, Jack L., MD, Ellis, Stephen G., MD, Colombo, Antonio, MD, Grube, Eberhard, MD, Maloney, Tom, MS, Friedman, Mark I., MD, Baim, Donald S., MD, Dawkins, Keith, MD, Caputo, Ron, MD, Stone, Gregg W., MD

“…Limited data are available on the relative effect of drug-eluting versus bare-metal stents on the requirement for subsequent coronary artery bypass grafting…”
Get full text

In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty : results from a randomized clinical trial by COHEN, D. J, KRUMHOLZ, H. M, DETRE, K, LEON, M. B, BAIM, D. S, SUKIN, C. A, HO, K. K. L, SIEGRIST, R. B, CLEMAN, M, HEUSER, R. R, BRINKER, J. A, MOSES, J. W, SAVAGE, M. P

“…Background Coronary stenting has been shown to improve initial success, reduce angiographic restenosis, and reduce the need for repeat revascularization…”
Get full text

Effect of Continuous Quality Improvement Analysis on the Delivery of Primary Percutaneous Transluminal Coronary Angioplasty for Acute Myocardial Infarction by Caputo, MD, Ronald P, Ho, MD, MSc, Kalon K.L, Stoler, MD, Robert C, Sukin, MD, Craig A, Lopez, MD, John J, Cohen,MD, MSc, David J, Kuntz, MD, MSc, Richard E, Berman, MD, Aaron, Carrozza, MD, Joseph P, Baim, MD, Donald S

“…A successful primary percutaneous transluminal coronary angioplasty (PTCA) program requires a learning process whereby the efficiency of the cardiac…”
Get full text

Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the bypass angioplasty revascularization investigation (BARI) by Williams, David O., Bairn, Donald S., Bates, Eric, Bonan, Raoul, Bost, James E., Cowley, Michael, Faxon, David P., Feit, Frederick, Jones, Robert, Kellett, Mirle A., Kelsey, Sheryl F., Sopko, George, Stadius, Michael, Topol, Eric J.

“…The Bypass Angioplasty Revascularization Investigation (BARI) is a randomized multicenter clinical trial that compares a strategy of initial coronary…”
Get full text

The Effects of Diltiazem and Reduced Serum Ionized Calcium on Ischemic Ventricular Fibrillation in the Dog by Clusin, William T, Bristow, Michael R, Bairn, Donald S, Schroeder, John S, Jaillon, Patrice, Brett, Peter, Harrison, Donald C

“…Calcium influx blockers reportedly suppress ventricular arrhythmias during acute ischemia. We therefore studied the effects of diltiazem and reduced serum…”
Get full text

Vascular complications of percutaneous femoral cardiac interventions. Incidence and operative repair by Skillman, J J, Kim, D, Baim, D S

“…Of 7333 patients undergoing percutaneous left-heart catheterization procedures during a seven-year seven-month period, 73 patients (1%) underwent 75 operative…”
Get more information